Tec Family Kinases | ||||||
---|---|---|---|---|---|---|
Protein | Protein size (kDa) | Tissue expression | Cell lineage expression | Chromosomal localization |
Activating pathway |
Phenotype of single mutation |
Tec29/dsrc29A/Dsrc29c | 66/55* | embryo, oocyte, imaginal disc | polytene chromosome 28c |
unknown | embryonic lethality and defective oogenesis |
|
Bmx/Etk | 80 | bone marrow, lung, testis, colon, heart | macrophage neutrophil | Xp22.2 (human) ? (mouse) |
IL-6R Gα12/13 |
unknown |
Btk /Bpk/Atk/Emb |
77 | bone marrow, spleen, lymph node, fetal liver | B, myeloid, erythroid, mast, megakaryocyte |
Xq22 (human) syntenic Xq22 (mouse) |
BcR, FcΕRI, gp130 (IL-6R), IL-5R, IL-10R, CD19, CD28 CD38, CD40 |
block in B cell development, defective BcR signaling and XLA, defective degranulation |
Itk/Tsk/Emt | 72 | thymus, spleen, lymph node | T, NK, mast cells |
5q31-32 (human) ? (mouse) |
TcR, CD28, CD2, FCΕRI | reduction in CD4+ subset and defect in TcR signalling |
Rlk/Txk | 52/58* | thymus, spleen, lymph node, tonsil, testis | T, myeloid | 4p12 (human) chromosome 5 (mouse) |
TcR | subtle, some reduction of IL-2 production |
Tec | 72/70/66/58* | bone marrow, spleen, thymus | T, B, myeloid, hepatocarcinoma | 4p12 (human) chromosome 5 (mouse) |
TcR, CD28, BcR, CD38, gp130, (IL-3R, IL-6R), EpoR, G-CSFR, TpoR, c kit, | unknown |
* Alternative splicing site of mRNA or alternative start site yields multiple isoforms.